AbCellera Biologics (ABCL) Goodwill & Intangibles (2020 - 2026)
AbCellera Biologics filings provide 7 years of Goodwill & Intangibles readings, the most recent being $85.3 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 4.19% to $85.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $85.3 million through Mar 2026, down 4.19% year-over-year, with the annual reading at $86.2 million for FY2025, 4.14% down from the prior year.
- Goodwill & Intangibles hit $85.3 million in Q1 2026 for AbCellera Biologics, down from $86.2 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $210.8 million in Q3 2022 and bottomed at $85.3 million in Q1 2026.
- Average Goodwill & Intangibles over 5 years is $141.6 million, with a median of $166.5 million recorded in 2024.
- The largest annual shift saw Goodwill & Intangibles soared 132.76% in 2022 before it tumbled 46.56% in 2025.
- AbCellera Biologics' Goodwill & Intangibles stood at $179.3 million in 2022, then decreased by 6.18% to $168.2 million in 2023, then plummeted by 46.55% to $89.9 million in 2024, then dropped by 4.14% to $86.2 million in 2025, then fell by 1.07% to $85.3 million in 2026.
- Per Business Quant, the three most recent readings for ABCL's Goodwill & Intangibles are $85.3 million (Q1 2026), $86.2 million (Q4 2025), and $87.1 million (Q3 2025).